|
A cohort study among workers exposed to benzene in China
|
Z01 CP010120-02060
|
$1,557,754
|
$311,551
|
Hayes, Richard
|
DCEG (NCI)
|
|
A Genome Wide RNAi Vulnerability Map for Myeloma
|
1R01CA133115-01
|
$270,000
|
$270,000
|
STEWART, A
|
MAYO CLINIC COLL OF MED, MAYO CLINIC AZ
|
|
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1
|
Z01 BC 011064
|
$228,515
|
$228,515
|
Mock, Beverly
|
CCR (NCI)
|
|
A Novel Antibody Therapeutic for Multiple Myeloma
|
2R44CA105840-02A2
|
$279,125
|
$279,125
|
CHINTALACHARUVU, KOTESWARA
|
CHIMERIC TECHNOLOGIES, INC.
|
|
AARP prospective study of diet and cancer
|
Z01 CP010196-03152
|
$2,416,410
|
$120,820
|
Schatzkin, Arthur
|
DCEG (NCI)
|
|
Adenosine Analogs: Therapeutics for Hematologic Cancers
|
3R01CA085915-08S1
|
$51,498
|
$25,749
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
Adenosine Analogs: Therapeutics for Hematologic Cancers
|
5R01CA085915-08
|
$311,663
|
$155,832
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
An anti-CD74 MAb-drug conjugate for B-cell malignancies
|
2R44CA108083-02A2
|
$492,190
|
$492,190
|
GOVINDAN, SERENGULAM
|
IMMUNOMEDICS, INC.
|
|
Animal Model and Genotyping Core Support Facility
|
Z01 BC 011047
|
$1,033,915
|
$206,783
|
DuBois, Wendy
|
CCR (NCI)
|
|
Anti-TfR IgG3-Av: A New Drug Against Multiple Myeloma
|
3R01CA107023-04S1
|
$86,240
|
$86,240
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Anti-TfR IgG3-Av: A New Drug Against Multiple Myeloma
|
5R01CA107023-04
|
$300,313
|
$300,313
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Anti-Tumor immunity in myeloma
|
7R01CA106802-05
|
$321,696
|
$321,696
|
DHODAPKAR, MADHAV
|
YALE UNIVERSITY
|
|
Antibody Neutralization of Therapeutic Viruses
|
1R01CA129966-01A1
|
$486,003
|
$486,003
|
RUSSELL, STEPHEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Application of SEREX antigen in multiple myeloma
|
5R01CA088434-11
|
$252,596
|
$252,596
|
Lim, Seah
|
HARRINGTON REGIONAL MEDICAL CENTER, INC.
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
Z01 BC 010856
|
$12,323,380
|
$1,232,338
|
Custer, Mary
|
CCR (NCI)
|
|
BCMA: Controlling the survival of differentiated B cells
|
5R01CA108896-05
|
$248,647
|
$248,647
|
NOELLE, RANDOLPH
|
DARTMOUTH COLLEGE
|
|
Biology of Multiple Myeloma Stem Cells
|
5K23CA107040-04
|
$138,510
|
$138,510
|
MATSUI, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Black/White PHS Study
|
Z01 CP010182-00430
|
$18,906
|
$4,726
|
Gail, Mitchell
|
DCEG (NCI)
|
|
Bone Marrow Grafting for Leukemia and Lymphoma
|
5P01CA049605-20
|
$3,446,067
|
$379,067
|
NEGRIN, ROBERT
|
STANFORD UNIVERSITY
|
|
Bone Marrow Transplantation in Human Disease
|
5P01CA015396-33
|
$2,910,583
|
$727,646
|
JONES, RICHARD
|
JOHNS HOPKINS UNIVERSITY
|
|
Bone-seeking proteasome inhibitors for myeloma
|
5K01CA113468-04
|
$149,240
|
$74,620
|
AGYIN, JOSEPH
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
|
Breast implant follow-up study
|
Z01 CP010128-01220
|
$31,576
|
$1,579
|
Brinton, Louise
|
DCEG (NCI)
|
|
Canadian Contribution to NCI Intergroup Program
|
2U10CA077202-11
|
$1,495,668
|
$74,783
|
MEYER, RALPH
|
QUEEN'S UNIVERSITY AT KINGSTON
|
|
Cancer and Leukemia Group B
|
5U10CA032291-27
|
$348,584
|
$17,429
|
WINER, ERIC
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer and Leukemia Group B
|
5U10CA047577-21
|
$166,705
|
$8,335
|
CRAWFORD, JEFFREY
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B
|
5U10CA077597-11
|
$121,638
|
$6,082
|
Liu, Minetta
|
GEORGETOWN UNIVERSITY
|
|
CANCER AND LEUKEMIA GROUP B
|
5U10CA077651-11
|
$266,414
|
$13,321
|
Hudis, Clifford
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Cancer and Leukemia Group B
|
5U10CA041287-23
|
$235,239
|
$11,762
|
FLEMING, GINI
|
UNIVERSITY OF CHICAGO
|
|
Cancer and Leukemia Group B
|
5U10CA031946-27
|
$10,968,655
|
$548,433
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
Cancer and Leukemia Group B
|
5U10CA037447-25
|
$1,580,095
|
$15,801
|
SCHILSKY, RICHARD
|
UNIVERSITY OF CHICAGO
|
|
Cancer and Leukemia Group B
|
5U10CA047559-18
|
$120,049
|
$6,002
|
SHEA, THOMAS
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer and Leukemia Group B
|
5U10CA003927-51
|
$206,830
|
$10,342
|
HURD, DAVID
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Cancer and Leukemia Group B - The Ohio State University
|
5U10CA077658-11
|
$450,518
|
$22,526
|
BLOOMFIELD, CLARA
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B Statistical Center
|
5U10CA033601-29
|
$5,067,063
|
$253,353
|
GEORGE, STEPHEN
|
DUKE UNIVERSITY
|
|
Cancer and Leukemia Group B-Leukemia Correlative Science
|
5U10CA101140-06
|
$1,000,836
|
$50,042
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Cancer and Leukemia Group B: RPCI/SUNYAB
|
5U10CA059518-16
|
$276,819
|
$13,841
|
LEVINE, ELLIS
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Cancer Center Core Support Grant
|
3P30CA016042-33S5
|
$4,587,184
|
$91,744
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Core Support Grant
|
3P30CA016042-33S6
|
$113,837
|
$2,277
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support (Core) Grant
|
2P30CA016672-33
|
$10,542,275
|
$421,691
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-33S1
|
$124,410
|
$4,976
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S1
|
$124,531
|
$2,491
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S2
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S3
|
$49,998
|
$1,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S4
|
$143,383
|
$2,868
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-44S5
|
|
$0
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-44
|
$11,641,774
|
$232,835
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Center Support Grant
|
3P30CA023108-30S1
|
$88,511
|
$2,655
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
5P30CA023108-30
|
$3,107,727
|
$93,232
|
ISRAEL, MARK
|
DARTMOUTH COLLEGE
|
|
Cancer Center Support Grant
|
2P30CA014599-33
|
$4,263,552
|
$42,636
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
Cancer Center Support Grant
|
3P30CA014599-33S1
|
$80,979
|
$810
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
Total relevant funding to Multiple Myeloma for this search: $41,541,846
|